Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose catheter-directed thrombolysis for intermediate-high risk pulmonary embolism
2018-003564-31Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of tissue-plasminogen activator in pulmonary embolism (PE) (2 arms), sponsored by Aarhus University Hospital. Primary endpoint: Change in RV/LV ratio on CT angiography. Started Feb 2019; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on 2018-003564-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003564-31.